incidence of pancreatitis with semaglutide Risk all–cause death and pancreatic events following GLP-1 RA initiation in people obesity or type 2 diabetes: observations from a federated research network | Cardiovascular Diabetology incidence of pancreatitis with semaglutide

Patients should seek immediate medical attention for severe, persistent abdominal pain (possibly radiating to the back) which could indicate pancreatitis

Skeptics rightfully note the limited long-term data

Seek Professional Advice Should your Tirzepatide back pain continue or worsen or allergic reaction occur, seek advice from a medical service professional who can assess if the discomfort stems from this medicine or an underlying condition that requires attention

For laboratory research use only

This is a serious problem for several reasons: Muscle loss slows your resting metabolic rate, making it harder to keep weight off after stopping the medication Reduced muscle mass increases the risk of falls, fractures, and loss of physical function particularly in older adults The skinny fat phenomenon normal BMI but high body fat percentage is a real outcome of poorly managed GLP-1 use The solution is not to avoid GLP-1 medications